InvestorsHub Logo
Followers 1
Posts 1474
Boards Moderated 0
Alias Born 08/25/2010

Re: conix post# 7709

Thursday, 03/01/2012 10:39:12 AM

Thursday, March 01, 2012 10:39:12 AM

Post# of 15274
..."What I find amazing is that someone thinks that his "research" on the internet overrides what the client "on the ground" knows..."...welllll...I do think that it's what the THIRD PARTY REIMBURSERS "think" that counts most for CTTC's BUSINESS...and, as I've posted before, this sums up nicely what they "think":

"Literature Review

Randomized controlled trials (RCTs)

There are no randomized trials that compared active with sham scrambler therapy. The only published RCT currently available was a small, short-term pilot study that compared scrambler therapy with pain medication in 55 patients matched for type of pain which included postoperative neuropathic pain, postherpetic neuralgia, or spinal canal stenosis.[1] The authors reported significantly greater pain reduction in the scrambler therapy group compared with the medication control group at 1-, 2-, and 3-month follow-up. While this RCT is useful in informing hypothesis formation, it does not permit conclusions on efficacy and safety due to small size, lack of a sham control group, and short-term followup period.

Nonrandomized trials

The remaining published trials are limited to nonrandomized trials.[2-4] Evidence from these studies is unreliable due to their inherent design flaws, such as non-random allocation of treatment, non-blind study design, and lack of comparison groups.

Clinical Practice Guidelines

There are no clinical practice guidelines from professional associations that recommend scrambler therapy.

Summary

The evidence is not sufficient to permit conclusions about the benefits of scrambler therapy as a treatment for pain from any etiology."

...and opening ONE clinic every 5 MONTHS probably isn't going to do much for CTTC's near term prospects...ESPECIALLY when no one bothers to advertise it -- don't you agree?...


Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.